Wyeth Reverses Last Year's Loss
92996
Wyeth WYE.N on Wednesday reported a  third-quarter profit compared to a year ago, when it took a  large charge for liabilities from its recalled "fen-phen" diet  medicines.
512787
SEVILLE, Spain  - England's Paul Casey fought off  the demons of regret to help steer his team to within a stroke  of the WGC World Cup first round lead Thursday.
668220
WILMINGTON, Del. -- Chemical company Hercules Inc. posted a third-quarter loss, weighed down by a charge, and said it will restate results for certain quarters after it reviewed its accounting practices.
214542
Small doses of Astellas Pharma Inc's Prograf did a better job at preventing rejection of a transplanted kidney than varying doses of other drugs including a low dose of Wyeth's Rapamune, researchers said on Wednesday.
653549
Shares of Wyeth WYE.N and Pfizer  Inc. PFE.N fell on Monday after Merrill Lynch downgraded the  drugmakers and U.K. regulators issued tougher warnings on the  type of popular depression drugs sold by the companies.
619949
Senior Mike McLaughlin returned from a three-week layoff to lead Woburn past Watertown, 35-12, in a Middlesex League football game yesterday.
383426
The auto parts maker reversed a year-earlier loss, supported by strength in its business outside North America and a broad restructuring.
622700
Great news -- your stock just got downgraded!
383006
Forest products company Weyerhaeuser Co.  posted a quarterly profit on Friday, after a year-ago loss, helped by gains from a refund on duties of Canadian lumber sold in the United States.
373392
Wyeth on Monday said it will support  proposed changes to a national settlement with former users of  its "fen-phen" diet drugs, allowing quicker settlements for  claims related to some of the less serious side effects from  the recalled appetite suppressants.
595740
Schering-Plough Corp. swung to a profit in the third quarter from a loss a year ago, even as sales decline slightly in the period.
636779
THE Kerry Packer-backed Challenger Financial Services Group handed down a $235 million full-year loss yesterday as Mike Tilley adopted the tried and tested strategy for incoming chief executives of cleaning up the books.
649682
The company turned in a wider Q1 loss but is still on track for a profitable year.
567343
The chief financial officer of Wyeth  WYE.N on Monday said the drug maker is considering whether to  repatriate up to $4 billion in profits earned overseas, but is  hesitant because of federal taxes that would have to be paid on  the returned funds.
149083
Power company Dynegy Inc. (DYN.N: Quote, Profile, Research) on Wednesday said it will restate results for 2003 and the first two quarters of this year to reflect a goodwill impairment
632510
Business & money: Sales back into positive territory after double-digit decline suffered earlier this year.
6179
U.S. drugmaker Wyeth  said on Wednesday it was maintaining its profit forecast for 2007, but added that first-quarter earnings would exceed current Wall Street average estimates of 85 cents per share.